These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 20801412

  • 1. Translation of stem cell therapy for neurological diseases.
    Schwarz SC, Schwarz J.
    Transl Res; 2010 Sep; 156(3):155-60. PubMed ID: 20801412
    [Abstract] [Full Text] [Related]

  • 2. Developmental perspectives on human midbrain-derived neural stem cells.
    Schwarz J.
    Parkinsonism Relat Disord; 2007 Sep; 13 Suppl 3():S466-8. PubMed ID: 18267285
    [Abstract] [Full Text] [Related]

  • 3. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C.
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H, Minger SL.
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A method for rapid derivation and propagation of neural progenitors from human embryonic stem cells.
    Axell MZ, Zlateva S, Curtis M.
    J Neurosci Methods; 2009 Nov 15; 184(2):275-84. PubMed ID: 19715727
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Stem cell-based therapy for Parkinson's disease.
    Correia AS, Anisimov SV, Li JY, Brundin P.
    Ann Med; 2005 Nov 15; 37(7):487-98. PubMed ID: 16278162
    [Abstract] [Full Text] [Related]

  • 12. Adult human neural stem cells for autologous cell replacement therapies for neurodegenerative disorders.
    Galvin KA, Jones DG.
    NeuroRehabilitation; 2006 Nov 15; 21(3):255-65. PubMed ID: 17167195
    [Abstract] [Full Text] [Related]

  • 13. The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.
    Drouin-Ouellet J.
    Neurodegener Dis Manag; 2014 Nov 15; 4(4):297-307. PubMed ID: 25313986
    [Abstract] [Full Text] [Related]

  • 14. Developmental perspectives on human midbrain-derived neural stem cells.
    Schwarz J, Schwarz SC, Storch A.
    Neurodegener Dis; 2006 Nov 15; 3(1-2):45-9. PubMed ID: 16909036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stem cell therapy for Parkinson's disease.
    Takahashi J.
    Expert Rev Neurother; 2007 Jun 15; 7(6):667-75. PubMed ID: 17563250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease.
    Bosch M, Pineda JR, Suñol C, Petriz J, Cattaneo E, Alberch J, Canals JM.
    Exp Neurol; 2004 Nov 15; 190(1):42-58. PubMed ID: 15473979
    [Abstract] [Full Text] [Related]

  • 19. Generation of dopamine neurons from embryonic stem cells in the presence of the neuralizing activity of bone marrow stromal cells derived from adult mice.
    Shintani A, Nakao N, Kakishita K, Itakura T.
    J Neurosci Res; 2008 Oct 15; 86(13):2829-38. PubMed ID: 18561325
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.